Chromatin/Epigenetics
Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
- Bromodomain(50)
- Aurora Kinase(63)
- DNA Methyltransferase(35)
- HDAC(210)
- Histone Acetyltransferases(78)
- Histone Demethylases(110)
- Histone Methyltransferase(240)
- HIF(102)
- JAK(173)
- MBT Domains(1)
- PARP(122)
- Pim(32)
- Protein Ser/Thr Phosphatases(34)
- RNA Polymerase(7)
- Sirtuin(77)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(246)
- MicroRNA(24)
- Protein Arginine Deiminase(7)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(44)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(1)
- METTL3(2)
- WDR5(1)
- TET Protein(2)
- HuR(1)
- SF3B1(1)
Chromatin/Epigenetics 相关产品(1617)
- GC14439Santacruzamate A (CAY10683)CAS: 1477949-42-0纯度: >99.00%
Santacruzamate A (CAY10683)是一种天然氨基甲酸酯衍生物,可抑制HDAC2和HDAC6活性,IC 50 值分别为0.119nM和434nM。
- GC14597ITSA-1 (ITSA1)CAS: 200626-61-5纯度: >98.00%
ITSA-1 (ITSA1)是一种组蛋白去乙酰化酶(HDAC)激活剂,可以防止动脉层流剪切力诱导的内皮细胞脱落,并降低血管内皮细胞(vECs)中VCAM-1的表达。
- GC15104(R)-(+)-Etomoxir sodium saltCAS: 828934-41-4纯度: >99.00%
(R)-(+)-Etomoxir sodium salt(Etomoxir; ETO)是一种用于代谢和心血管疾病的小分子,经酶转化为活性抑制剂乙托莫西里尔辅酶a (IC50 约为0.01-0.70 µM)后,对CPT-1a和CPT-1b的抑制表现出纳摩尔效价。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14439 | Santacruzamate A (CAY10683) | 1477949-42-0 | >99.00% | |
Santacruzamate A (CAY10683)是一种天然氨基甲酸酯衍生物,可抑制HDAC2和HDAC6活性,IC 50 值分别为0.119nM和434nM。 | ||||
| GC14524 | CTPB | 586976-24-1 | >98.00% | |
A selective activator of p300 HAT | ||||
| GC14566 | CCT137690 | 1095382-05-0 | >99.00% | |
An inhibitor of Aurora kinases and FLT3 | ||||
| GC14585 | GSK591 | 1616391-87-7 | >99.50% | |
A chemical probe for PRMT5 | ||||
| GC14592 | KW 2449 | 1000669-72-6 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC14597 | ITSA-1 (ITSA1) | 200626-61-5 | >98.00% | |
ITSA-1 (ITSA1)是一种组蛋白去乙酰化酶(HDAC)激活剂,可以防止动脉层流剪切力诱导的内皮细胞脱落,并降低血管内皮细胞(vECs)中VCAM-1的表达。 | ||||
| GC14631 | SP2509 | 1423715-09-6 | >99.50% | |
A reversible inhibitor of LSD1 | ||||
| GC14655 | OXF BD 02 | 1429129-68-9 | - | |
OXF BD 02 是 BRD4(1)(BRD4 的第一个溴结构域)的选择性抑制剂,IC50 值为 382 nM。 | ||||
| GC14676 | Pacritinib (SB1518) | 937272-79-2 | - | |
An equipotent inhibitor of FLT3 and JAK2 | ||||
| GC14686 | JFD00244 | 96969-83-4 | >98.00% | |
An inhibitor of SIRT2 | ||||
| GC14699 | CPI-203 | 1446144-04-2 | >99.00% | |
A bioavailable inhibitor of BET bromodomains | ||||
| GC14755 | Inauhzin | 309271-94-1 | >99.00% | |
A selective SIRT1 inhibitor | ||||
| GC14756 | EI1 | 1418308-27-6 | >99.50% | |
A selective inhibitor of EZH2 | ||||
| GC14763 | WDR5 0103 | 890190-22-4 | >98.00% | |
An inhibitor of WDR5 peptide binding | ||||
| GC14787 | Curcumin | 458-37-7 | >98.00% | |
A yellow pigment with diverse biological activities | ||||
| GC14857 | LFM-A13 | 244240-24-2 | >99.50% | |
A BTK inhibitor | ||||
| GC14875 | NSC 663284 | 383907-43-5 | >99.50% | |
Inhibitor of Cdc25 isoforms | ||||
| GC14938 | PF-03394197(Oclacitinib) | 1208319-26-9 | - | |
A JAK family kinase inhibitor | ||||
| GC14998 | Rocilinostat (ACY-1215) | 1316214-52-4 | >98.00% | |
A selective inhibitor of HDAC6 | ||||
| GC15041 | Tankyrase Inhibitors (TNKS) 22 | - | - | |
Tankyrase inhibitor | ||||
| GC15049 | MCB-613 | 1162656-22-5 | >99.50% | |
A small molecule stimulator of SRCs | ||||
| GC15102 | EPZ020411 | 1700663-41-7 | >98.00% | |
EPZ020411是一种具有高效选择性,且口服生物利用度高的蛋白质精氨酸甲基转移酶6(PRMT6)抑制剂,IC 50 值为10nM。 | ||||
| GC15104 | (R)-(+)-Etomoxir sodium salt | 828934-41-4 | >99.00% | |
(R)-(+)-Etomoxir sodium salt(Etomoxir; ETO)是一种用于代谢和心血管疾病的小分子,经酶转化为活性抑制剂乙托莫西里尔辅酶a (IC50 约为0.01-0.70 µM)后,对CPT-1a和CPT-1b的抑制表现出纳摩尔效价。 | ||||
| GC15106 | CYC116 | 693228-63-6 | >98.00% | |
A potent Aurora kinase inhibitor | ||||
